Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |